Blood pressure lowering in patients with diabetes—one level might not fit all

Por Cooper-DeHoff, Rhonda M., Egelund, Eric F., Pepine, Carl J.
Publicado em 2010

CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?

Por Obeng, Aniwaa Owusu, Egelund, Eric F., Alsultan, Abdullah, Peloquin, Charles A., Johnson, Julie A.
Publicado em 2014

Voriconazole Monitoring in Children with Invasive Fungal Infections

Por Tucker, Lyn, Higgins, Tara, Egelund, Eric F., Zou, Baiming, Vijayan, Vini, Peloquin, Charles A.
Publicado no J Pediatr Pharmacol Ther (2015)

Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers

Por Weiner, Marc, Egelund, Eric F., Engle, Melissa, Kiser, Melissa, Prihoda, Thomas J., Gelfond, Jonathan A. L., Mac Kenzie, William, Peloquin, Charles A.
Publicado em 2014

Protein Binding of Rifapentine and Its 25-Desacetyl Metabolite in Patients with Pulmonary Tuberculosis

Por Egelund, Eric F., Weiner, Marc, Singh, Rajendra P., Prihoda, Thomas J., Gelfond, Jonathon A. L., Derendorf, Hartmut, Mac Kenzie, William R., Peloquin, Charles A.
Publicado em 2014